Introduction. Diabetes Mellitus causes ultrastructural changes triggered by partially clarified cellular mechanisms. Since cell death is an important mechanism in the appearance and progression of diabetic nephropathy, we studied alteration of several markers of apoptotic pathways signaling in renal tissue of diabetic or prediabetic patients.
Methods. We analyzed 48 human kidney tissue samples divided into two study groups: the research group (43 renal tissue samples from diabetic or prediabetic patients), and the control group (5 renal tissue samples from patients without diabetes). Immunohistochemistry revealed expression of Bcl-2, APAF-1, CD-95 and Caspase-9 in the renal cortical structures. Statistical analysis was also performed (significance level P<0.05).
Results. We found a variable expression of the antiapoptotic Bcl-2 with a decrease of Bcl-2 expression in diabetes. The control samples render evident intensely positive immunostaining for CD-95. In diabetes and diabetic nephropathy, there was positive immunostaining for APAF-1 at tubular cell level. Nuclear and cytoplasmic positivity for Caspase-9 was more frequently recorded as kidney damage progresses. APAF-1 and Caspase-9 positivity are arguments for an intrinsic apoptotic mechanism of cell death in diabetic nephropathy.
Conclusion. The mechanisms of apoptotic cell death identified in diabetic kidney samples prove that Bcl-2, CD-95, APAF-1 and Caspase-9 represent reliable markers of cell death in human renal tissue. Our results support the hypothesis that apoptosis is a pathogenic and initiator mechanism of renal remodeling in diabetic kidney disease.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. IFKF. World Kidney Day -Kidney Health for All. 2015 [cited 17.08.2015]; Available from: http://www.worldkidneyday.org/topics/diabetes/http://www.niddk.nih.gov/health-information/health-topics/kidney-disease/kidney-disease-of-diabetes/Documents/kdd_508.pdf
2. WHO. Diabetes Fact sheet N°312. 2015 January 2015 [cited 28.02.2015]; Available from: http://www.who.int/mediacentre/factsheets/fs312/en/
3. WHO. Noncommunicable diseases - Fact sheet 2015 January 2015 [cited 31.07.2015]; Available from: http://www.who.int/mediacentre/factsheets/fs355/en/
4. BATUMAN V SOMAN A SCHMIDT R SOMAN S. Diabetic Nephropathy. [cited 07.05.2015] Available from: http://emedicine.medscape.com/article/238946-overview.
5. ADA Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes. 2015; 33(2): 97-111.
6. HOTCHKISS RS STRASSER A McDUNN JE SWANSON PE. Cell death. N Engl J Med. 2009; 361(16): 1570-83.
7. ELMORE S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35(4): 495-516.
8. DING Y CHOI ME. Autophagy in diabetic nephropathy. J Endocrinol. 2015; 224(1): R15-30.
9. SANCHEZ-NINO MD BENITO-MARTIN A ORTIZ A. New paradigms in cell death in human diabetic nephropathy. Kidney Int. 2010; 78(8): 737-44.
10. SINKOVICS JG. Programmed cell death (apoptosis): its virological and immunological connections (a review). Acta Microbiol Hung. 1991; 38(3-4): 321-34.
11. CABON L MARTINEZ-TORRES AC SUSIN SA. Programmed cell death comes in many flavors. Med Sci (Paris). 2013; 29(12): 1117-24.
12. ACEHAN D JIANG X MORGAN DG HEUSER JE WANG X AKEY CW. Three-dimensional structure of the apoptosome: implications for assembly procaspase-9 binding and activation. Mol Cell. 2002; 9(2): 423-32.
13. OO TF SIMAN R BURKE RE. Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra. Exp Neurol. 2002; 175(1): 1-9.
14. ALPERN R CAPLAN M MOE O. Seldin and Giebisch's the kidney; Physiology & pathophysiology. Academic Press; 2012. p. 2605-23.
15. RANE MJ SONG Y JIN S BARATI MT WU R KAUSAR H et al. Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy. Am J Physiol Renal Physiol. 2010; 298(1): F49-61.
16. WOLF G SCHROEDER R ZIYADEH FN THAISS F ZAHNER G STAHL RA. High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: relationship to hypertrophy. Am J Physiol. 1997; 273(3 Pt 2): F348-56.
17. DAVIS RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993; 268(20): 14553-6.
18. MARTIN AG FEARNHEAD HO. Apocytochrome c blocks caspase-9 activation and Bax-induced apoptosis. J Biol Chem. 2002; 277(52): 50834-41.
19. YANG E ZHA J JOCKEL J BOISE LH THOMPSON CB KORSMEYER SJ. Bad a heterodimeric partner for Bcl-XL and Bcl-2 displaces Bax and promotes cell death. Cell. 1995; 80(2): 285-91.
20. NEWMEYER DD BOSSY-WETZEL E KLUCK RM WOLF BB BEERE HM GREEN DR. Bcl-xL does not inhibit the function of Apaf-1. Cell Death Differ. 2000; 7(4): 402-7.
21. ALMOND JB COHEN GM. The proteasome: a novel target for cancer chemotherapy. Leukemia. 2002; 16(4): 433-43.
22. TOWNS R PIETROPAOLO M WILEY JW. Stimulation of autophagy by autoantibody-mediated activation of death receptor cascades. Autophagy. 2008; 4(5): 715-6.
23. FALEIRO L LAZEBNIK Y. Caspases disrupt the nuclear-cytoplasmic barrier. J Cell Biol. 2000; 151(5): 951-9.
24. KRAMER A LIASHKOVICH I OBERLEITHNER H SHAHIN V. Caspase-9-dependent decrease of nuclear pore channel hydrophobicity is accompanied by nuclear envelope leakiness. Nanomedicine. 2010; 6(5): 605-11.
25. BĂLĂŞESCU E DUŢĂ I RUSU MC. Human diabetic nephropathy: TRADD-positive and bcl2-negative podocytes. Therapeutics Pharmacology and Clinical Toxicology. 2013;17(3):115-8.